{"id":52321,"date":"2021-05-04T16:41:00","date_gmt":"2021-05-04T16:41:00","guid":{"rendered":"https:\/\/www.verificat.cat\/kovivac-work\/"},"modified":"2021-05-04T16:41:00","modified_gmt":"2021-05-04T16:41:00","slug":"kovivac-work","status":"publish","type":"post","link":"https:\/\/www.verificat.cat\/en\/kovivac-work\/","title":{"rendered":"Kovivac"},"content":{"rendered":"<p><br \/>\n<\/p>\n<p>Russia <a href=\"http:\/\/www.chumakovs.ru\/en\/\" target=\"_blank\" rel=\"noopener\">has approved<\/a> its third vaccine, developed by the Chumakov Federal Scientific Center for Research and Development of Biological and Immune Products of the Russian Academy of Sciences. The vaccine was due to start being administered in the second half of March, although as of 25 March <a href=\"https:\/\/russkiymir.ru\/en\/news\/286024\/\" target=\"_blank\" rel=\"noopener\">it had not yet been used <\/a>to immunise the population.<\/p>\n<p>It is a <a href=\"http:\/\/government.ru\/en\/news\/41342\/\" target=\"_blank\" rel=\"noopener\">virus inactivated<\/a> vaccine, that consists of the inoculation of a dead version of the virus able to trigger an immune response, but not being able to cause the disease. The vaccine <a href=\"https:\/\/covid19.trackvaccines.org\/vaccines\/100\/\" target=\"_blank\" rel=\"noopener\">has not yet started phase III<\/a> of the clinical trials. In the first two, which started in September 2020, a total of <a href=\"https:\/\/clinline.ru\/reestr-klinicheskih-issledovanij\/502-21.09.2020.html\" target=\"_blank\" rel=\"noopener\">600 volunteers<\/a> participated.&nbsp;<\/p>\n<p>The injection will be administered in two doses separated 14 days each other, and are stored at a temperature between 2&ordm; and 8&ordm;C, as Deputy Prime Minister <a href=\"http:\/\/government.ru\/en\/news\/41342\/\" target=\"_blank\" rel=\"noopener\">Tatiana Golikova<\/a> informed in a press release in January. She there assured that the vaccine is completely sure and the majority of volunteers developed a stable immunity after 28 days, without specifying the efficacy. There are no published results yet.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Russia has approved its third vaccine, developed by the Chumakov  [&#8230;]<\/p>\n","protected":false},"author":15,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[169],"tags":[208],"class_list":["post-52321","post","type-post","status-publish","format-standard","hentry","category-uncategorized","tag-vaccines-en","vc-legacy-post"],"acf":[],"_links":{"self":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts\/52321","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/users\/15"}],"replies":[{"embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/comments?post=52321"}],"version-history":[{"count":0,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/posts\/52321\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/media?parent=52321"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/categories?post=52321"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.verificat.cat\/en\/wp-json\/wp\/v2\/tags?post=52321"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}